Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 1Pancreatic Neoplasms 1Neoplasms 1Hematologic Neoplasms 1Epilepsy 1Digestive System Diseases 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Abdominal Cancer Surgeries 1

Interventions

Bevacizumab 2trifluridine tipiracil drug combination 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Oxaliplatin 1Oviposition 1Nivolumab 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1IDRX-42 1Hydromorphone 1Fluorouracil 1Fentanyl 1Drug Therapy 1Drainage 1Dietary Supplements 1Colonoscopy 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Diseases × Fentanyl × 1 year × Clear all
NCT03214510 2026-03-05

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
101 enrolled

Digestive System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡